World-Renowned PGD Researcher Educates Physicians & Healthcare Professionals About Preventing Birth Defects & Infant Mortality At March of Dimes Conference

Media Contact: Annamarie Santana (949) 726-0600
asantana@coastalfertility.com

World-Renowned PGD Researcher Educates Physicians & Healthcare Professionals About Preventing Birth Defects & Infant Mortality At March of Dimes Conference 

Wednesday, Jan. 19 –9:45 AM- Long Beach Convention Center

WHAT: World-renowned fertility expert and leader in reproductive medicine Dr. Lawrence Werlin will be the featured speaker at the 5th Annual March of Dimes Conference. This year’s theme, “Preventing Birth Defects & Infant Mortality — Prematurity: Minimizing Risk & Maximizing Outcome,” will educate health care providers on the most common causes of perinatal mortality and birth defects.

Werlin’s presentation, “Artificial Reproduction Therapy: Risk of Birth Defects,” will explore new developments in reproductive medicine that will aid healthcare providers in the prevention and early detection of birth defects including the use of preimplantation genetic diagnosis (PGD).

WHY: March of Dimes and the Community Perinatal Network have partnered to focus on these critical issues at this year’s conference due to the increasing problem of premature births in the United States, and the impact this trend is having on the overall health of children.

WHERE: Westin Hotel & Resort in Long Beach, 333 East Ocean Boulevard

WHEN: Wednesday, January 19– 9:45 a.m. – Conference Presentation

WHO: Dr. Werlin is the principal investigator and a world-renowned leader in the uses and study of PGD, and the co-founder of GENESIS Network for Reproductive Health. For his expertise, Werlin speaks globally as a noted authority, and was recently invited to participate as an expert consultant at the European Society of Human Reproduction and Embryology (ESHRE) conference in Berlin, Germany.

PGD is gaining national and international attention for what it offers. PGD screens and tests for abnormal chromosomes in the beginning stages of in-vitro fertilization, offering valuable information early on for prospective parents about success rates and likelihood for passing on genetic diseases.

MEDIA OPPORTUNITIES:
– Werlin is available for in-person and/or informational interviews prior to his presentation.
– Press attendance at the conference is also welcome and should be confirmed in advance by calling (714) 573-2746.

CONTACT: 
Patients – For an appointment, please call Coastal Fertility at (949) 726-0600 or visit us at http://www.coastalfertility.com.
Media – For more information or to request an interview, please contact Annamarie Santana at (949) 726-0600 or asantana@coastalfertility.com.